Medicines Australia disappointed by TPP outcomes

The outcomes of the negotiations for the Trans-Pacific Partnership agreed to in Atlanta overnight are a disappointing outcome and a missed opportunity to stimulate and grow the Australian biopharmaceutical industry, says Medicines Australia. "Just last month, the Prime Minister declared that innovation would be at the centre of the Federal Government; the decision not to